About Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
During the past decade, Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on
average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI"
#1 collaborator was "AOP Orphan Pharmaceuticals AG" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
According to Clinical.Site data, the most researched conditions in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI" are
"Follicular Lymphoma" (2 trials), "Polycythemia Vera" (2 trials), "CD20 Positive Diffuse Large B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "DLBCL" (1 trials). Many other conditions were trialed in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI" in a lesser frequency.
Clinical Trials Intervention Types at Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
Most popular intervention types in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI" are "Drug" (12 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (2 trials), "AOP2014" (1 trials), "ASA" (1 trials), "Bendamustine+Rituximab" (1 trials) and "Bortezomib-Rituximab-Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
The vast majority of trials in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI" are
16 trials for "All" genders.
Clinical Trials Status at Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI
Currently, there are NaN active trials in "Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI".
1 are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".